CENTRAL NERVOUS SYSTEM STIMULANTS

Brand Owner (click to sort) Address Description
ALZENIA Cerebral Health 1100 Sioux Street Jupiter FL 33458 Central nervous system stimulants;
ATTUNEX NextWave Pharmaceuticals Incorporated Attn: Ketan Mehta 2033 Route 130, Suite D Monmouth Junction CA 08852 Central nervous system stimulants; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; liquid pharmaceutical preparations for use as central nervous system stimulants; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; central nervous system stimulants, namely methylphenidate hydrochloride;ATTUNE X;
KICKIN' ENERGY Novelty, Inc. 351 W. Muskegon Dr. Greenfield IN 46140 Central nervous system stimulants; Dietary supplemental drinks;KICKING ENERGY;ENERGY;
RECEPTRIN NextWave Pharmaceuticals Incorporated Attn: Ketan Mehta 2033 Route 130, Suite D Monmouth Junction CA 08852 Central nervous system stimulants; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; liquid pharmaceutical preparations for use as central nervous system stimulants; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; central nervous system stimulants, namely methylphenidate hydrochloride;
WAIT NO MORE-2 206 MACOPIN CORP 206 MACOPIN RD BLOOMINGDALE NJ 07403 central nervous system stimulants;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Methods and compositions for modulating the axonal outgrowth of central nervous system neurons are provided. Methods for stimulating the axonal outgrowth of central nervous system neurons following an injury (e.g., stroke, Traumatic Brain Injury, cerebral aneurism, spinal cord injury and the like) and methods for inhibiting the axonal outgrowth of central nervous system neurons in conditions such as epilepsy, e.g., posttraumatic epilepsy, and neuropathic pain syndrome, are also provided. These methods generally involve contacting the central nervous system neurons with a compound that modulates the activity of N-kinase, or analog thereof. The methods and compositions are particularly useful for modulating the axonal outgrowth of mammalian central nervous system neurons, such as mammalian cortical neurons or retinal ganglion cells. Pharmaceutical and packaged formulations that include the compounds of the invention that modulate the activity of N-kinase are also provided.